The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine

Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor–mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects

(2016) Borje Darpo et al.   CLINICAL THERAPEUTICS

Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers

(2016) Stephen A. Bai et al.   CLINICAL THERAPEUTICS

Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology

(2016) Joseph Pergolizzi et al.   Journal of Pain Research

Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment

(2014) Haitao Yang et al.   Expert Opinion on Drug Metabolism & Toxicology

Buccal and sublingual vaccine delivery

(2014) Heleen Kraan et al.   JOURNAL OF CONTROLLED RELEASE

Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers

(2013) Andreas Fischer et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Buprenorphine

(2013) Bethany Foster et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Opioid Rotation in Clinical Practice

(2012) Srinivas R. Nalamachu   ADVANCES IN THERAPY

Pharmacokinetic–pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature

(2011) Christian Martini et al.   Expert Review of Clinical Pharmacology

Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

(2010) Joseph Pergolizzi et al.   Pain Practice

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

(2008) Hans G. Kress   EUROPEAN JOURNAL OF PAIN

Hypogonadism in men receiving methadone and buprenorphine maintenance treatment

(2007) R. Hallinan et al.   INTERNATIONAL JOURNAL OF ANDROLOGY